8-KItem 5.02 · Officer/Director ChangeItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements

Zimmer Biomet promotes three leaders in Americas commercial restructuring

Filed with the SEC on · Summarized by InvestorsBot

Zimmer Biomet announced that, effective October 1, 2026, Gary Campbell will become President, Americas; Brian Hatcher will lead Recon, S.E.T., CMFT, Neuro and Biosurgery; and Bradley Kessler will lead Americas Robotics, Technology and Data. Kevin Thornal, Group President of Global Businesses and the Americas, will leave the company on September 30 after a transition period; Zimmer Biomet also reiterated its full-year 2026 financial outlook and said the changes support its U.S. commercial transformation and preparation for the expected 2027 launch of its Monogram orthopedic robot.

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from ZIMMER BIOMET HOLDINGS, INC.